Chill
Oral Solution with a Combination of pure cannabinoids (CBD, 300 mg per bottle) for Relaxation and Calming Support
$79.99
5.00/5
Menu
We create each of our cannabinoid treatments just for dogs. Downsized human treatments? Not here. Only the molecules needed to treat your pet’s ailment? Naturally.
Our products are formulated for maximum absorption to increase effectiveness. And with tasty treat appeal, you won’t have to beg them to take their medicine.
Sign up. Stay informed. Save.
© Copyright 2022 CHOU2 PHARMA. All Rights Reserved. Privacy Policy. Terms & Conditions.
In her role as Vice President of Sales, Julie Griggs offers CHOU2 PHARMA the insights and knowledge gained throughout her career in veterinary medicine.
After serving pets and their families as a certified veterinary technician, Ms. Griggs went on to become a practice manager for a veterinary group with a portfolio of more than 1,000 neighborhood hospitals across the U.S. and Puerto Rico. From there she transitioned into pet pharmaceutical management and sales, holding key positions in top companies including Zoetis, Covetrus, Antech Diagnostics and LexaGene.
Along the way, Ms. Griggs witnessed the growing desire for high-quality natural pet solutions. Her position at CHOU2 PHARMA gives her the opportunity to help answer that need. Leveraging her experience with the inner workings of hospitals, she connects with the veterinarians and distributors who select the right products to offer their clients and patients. She works with hospitals and clinics to market and sell CHOU2 PHARMA formulas, and always enjoys the chance to introduce our brand to new people through trade shows, lunch-and-learns and other outreach programs. Working on retail placement is another way Ms. Griggs works to ensure our products reach the pets who need them most.
Mark Cushing leads CHOU2 PHARMA’s advocacy and legal efforts—working closely with his external network and Dr. Jeff Pollard—to improve the understanding, education and policy regarding cannabinoid pet health care. His focus is supporting veterinarians’ ability to discuss and recommend cannabinoid-based products within their practices.
Mr. Cushing provides high-level strategic advice, state and federal lobbying, regulatory and policy services and consulting to animal health and veterinary clients throughout North America. Since 2004, he has specialized in animal health, animal welfare, veterinary and veterinary educational issues, developing a cutting-edge practice across these sectors. He currently leads several industry coalitions and initiatives. Mr. Cushing has guided successful AVMA (American Veterinary Medical Association) accreditations for a growing list of veterinary colleges, including new accreditations.
A frequent speaker at veterinary medicine and other animal policy conferences, he’s an adjunct professor of law at the Duncan School of Law in Knoxville, Lewis & Clark Law School in Portland and the University of Oregon School of Law. He’s also an honors graduate with distinction from Stanford University and the Willamette University College of Law.
As the founder and managing partner of the Animal Policy Group, LLC (APG), Mr. Cushing offers representation for a wide range of veterinary and pet health interests. Most recently, Mr. Cushing authored Pet Nation, a Penguin Random House title that explores the forces behind pets becoming treasured members of the family.
Mark Cushing leads CHOU2 PHARMA’s advocacy and legal efforts—working closely with his external network and Dr. Jeff Pollard—to improve the understanding, education and policy regarding cannabinoid pet health care. His focus is supporting veterinarians’ ability to discuss and recommend cannabinoid-based products within their practices.
Mr. Cushing provides high-level strategic advice, state and federal lobbying, regulatory and policy services and consulting to animal health and veterinary clients throughout North America. Since 2004, he has specialized in animal health, animal welfare, veterinary and veterinary educational issues, developing a cutting-edge practice across these sectors. He currently leads several industry coalitions and initiatives. Mr. Cushing has guided successful AVMA (American Veterinary Medical Association) accreditations for a growing list of veterinary colleges, including new accreditations.
A frequent speaker at veterinary medicine and other animal policy conferences, he’s an adjunct professor of law at the Duncan School of Law in Knoxville, Lewis & Clark Law School in Portland and the University of Oregon School of Law. He’s also an honors graduate with distinction from Stanford University and the Willamette University College of Law.
As the founder and managing partner of the Animal Policy Group, LLC (APG), Mr. Cushing offers representation for a wide range of veterinary and pet health interests. Most recently, Mr. Cushing authored Pet Nation, a Penguin Random House title that explores the forces behind pets becoming treasured members of the family.
